Coinfection takes its toll: Sea lice override the protective effects of vaccination against a bacterial pathogen in Atlantic salmon
Vaccination is considered crucial for disease prevention and fish health in the global salmon farming industry. Nevertheless, some aspects, such as the efficacy of vaccines, can be largely circumvented during natural coinfections. Sea lice are ectoparasitic copepods that can occur with a high preval...
| Published in: | Scientific Reports |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article in Journal/Newspaper |
| Language: | English |
| Published: |
Springer Nature
2017
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10012/12769 https://doi.org/10.1038/s41598-017-18180-6 |
| Summary: | Vaccination is considered crucial for disease prevention and fish health in the global salmon farming industry. Nevertheless, some aspects, such as the efficacy of vaccines, can be largely circumvented during natural coinfections. Sea lice are ectoparasitic copepods that can occur with a high prevalence in the field, are frequently found in co-infection with other pathogens, and are highly detrimental to fish health. The aim of this case-control study was to evaluate the interaction between the detrimental effects of coinfection and the protective effects of vaccination in fish. We used the interaction between the sea louse Caligus rogercresseyi, the bacterial pathogen Piscirickettsia salmonis, and their host, the Atlantic salmon Salmo salar, as a study model. Our results showed that coinfection decreased the accumulated survival (AS) and specific growth rate (SGR) of vaccinated fish (AS = 5.2 ± 0.6%; SGR = −0.05 ± 0.39%) compared to a single infection of P. salmonis (AS = 42.7 ± 1.3%; SGR = 0.21 ± 0.22%). Concomitantly, the bacterial load and clinical signs of disease were significantly increased in coinfected fish. Coinfection may explain the reduced efficacy of vaccines in sea cages and highlights the need to test fish vaccines in more diverse conditions rather than with a single infection. CONICYT-Chile though project FONDECYT N°1140772 Cooperative Research Programme Fellowships of OECD (PCI 2015-CONICYT) awarded to J.A.G and P.C. C.F. was supported by PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO (Proyecto VRIEA-PUCV Postdoctorado) and CONICYT-Chile as a Postdoctoral fellowship (FONDECYT N°3170744) D.T. was supported by CONICYT-Chile as a Postdoctoral fellowship (FONDECYT N° 74170029) |
|---|